| Madhulika Krish, MD | |
|
4318 W Okmulgee St, Muskogee, OK 74401-4648 | |
| (918) 686-0471 | |
| (918) 686-9471 |
| Full Name | Madhulika Krish |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 4318 W Okmulgee St, Muskogee, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538168505 | NPI | - | NPPES |
| 100850740C | Other | OK | SOONER CARE |
| 100850740A | Medicaid | OK | |
| 5M288 | Other | AR | BLUE CROSS BLUE SHIELD |
| 146877001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 30460 (Oklahoma) | Primary |
| 207Q00000X | Family Medicine | E3302 (Arkansas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dallas County Medical Center | Fordyce, AR | Hospital |
| Mcgehee Hospital | Mcgehee, AR | Hospital |
| Mena Regional Health System | Mena, AR | Hospital |
| Alliancehealth Woodward | Woodward, OK | Hospital |
| Chicot Memorial Medical Center | Lake village, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ess Of Fordyce Llc | 1254611601 | 15 |
| Ess Of Mcgehee Llc | 0749677516 | 16 |
| Hospital Care Consultants Of Fordyce Llc | 5395024475 | 2 |
| Hcc Of Shattuck Llc | 8628401262 | 6 |
| Hospital Care Consultants Inc | 9032131735 | 12 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Mercy Hospital Paris |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912955709 PECOS PAC ID: 0244135705 Enrollment ID: O20031206000120 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Integrated Community Clinics Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760440226 PECOS PAC ID: 2567361165 Enrollment ID: O20040102000477 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Mercy Hospital Waldron |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730137134 PECOS PAC ID: 5597658005 Enrollment ID: O20040211000825 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Mercy Hospital Ozark |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881642767 PECOS PAC ID: 3678467412 Enrollment ID: O20040211001144 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Mercy Hospital Ozark |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1275504128 PECOS PAC ID: 3678467412 Enrollment ID: O20040428001328 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Correct Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215987441 PECOS PAC ID: 8628980992 Enrollment ID: O20041207001183 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Mercy Hospital Paris |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1760453633 PECOS PAC ID: 0244135705 Enrollment ID: O20061104000304 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Mercy Hospital Paris |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518915321 PECOS PAC ID: 0244135705 Enrollment ID: O20090402000673 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Arkansas Emergency Staffing Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275774630 PECOS PAC ID: 3274681341 Enrollment ID: O20090501000014 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Mercy Hospital Booneville |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1992133714 PECOS PAC ID: 1951530385 Enrollment ID: O20140312001275 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Hospital Care Consultants Of Fordyce Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316497464 PECOS PAC ID: 5395024475 Enrollment ID: O20161112000042 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Ess Of Fordyce Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821547977 PECOS PAC ID: 1254611601 Enrollment ID: O20161201001070 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Mercy Hospital Booneville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083004733 PECOS PAC ID: 1951530385 Enrollment ID: O20170203001490 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Entity Name | Ess Of Mcgehee Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639822653 PECOS PAC ID: 0749677516 Enrollment ID: O20220426000293 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Madhulika Krish, MD 4318 W Okmulgee St, Muskogee, OK 74401-4648 Ph: (918) 686-0471 | Madhulika Krish, MD 4318 W Okmulgee St, Muskogee, OK 74401-4648 Ph: (918) 686-0471 |
News Archive
Medical Innovation, the leading event for civilian and military healthcare professionals, has today announced a unique opportunity for the world's most innovative medical suppliers to present their latest solutions to the UK Armed Forces through an open call for innovation.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.
› Verified 6 days ago
Jeremy Michael Ross, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 S 38th St Ste A, Muskogee, OK 74401 Phone: 918-682-8631 Fax: 918-686-7078 | |
Dr. Michael W Hammond, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 3900 W Broadway St, Muskogee, OK 74401 Phone: 918-682-8612 Fax: 918-682-0620 | |
Dr. B Frank Shaw, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2901 Azalea Park Drive, Muskogee, OK 74401 Phone: 918-683-6500 | |
Dr. Charles D Rogers, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1011 Honor Heights Dr, Muskogee, OK 74401 Phone: 918-683-3261 | |
Dr. Patrice Diane Pace, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3300 Chandler Rd Ste 107, Muskogee, OK 74403 Phone: 800-993-8244 Fax: 404-494-7537 | |
Rebekah Jean Martin Kriegsman, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Rockefeller Dr Ste 203, Muskogee, OK 74401 Phone: 918-910-4300 Fax: 918-910-4315 | |
Dr. Harold L Demoss, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1001 S 41st St E, Muskogee, OK 74403 Phone: 918-781-6500 |